Training session on the new pharmaceutical legislation
EventCorporate
Date
Location
This training session for patient- and consumer-organisation representatives is focusing on the new pharmacovigilance legislation; the Pharmacovigilance Risk Assessment Committee (PRAC); risk-management plans and post-authorisation safety studies; adverse-drug-reaction reporting and signal detection; periodic safety update reports; safety referrals; and the impact of the pharmacovigilance legislation.